How Artificial Intelligence Can Combat The Opioid Abuse Epidemic [transcript] [audio]

Guest: Brad Bostic

Presenter: Neal Howard

Guest Bio: Brad Bostic was inspired to improve healthcare service levels when his mother was battling cancer and her journey exposed that most healthcare professionals did not understand her unique needs. Brad founded hc1.com to create a new approach to healthcare relationship management that analyzes relationships and behaviors with advanced cloud technology to drive positive change. Brad serves on the Techpoint board, Indiana University Dean’s Advisory Council, and is a member of the Indiana Chamber of Commerce. Brad is also a member of Young Presidents Organization (YPO) and has been recognized on the Indianapolis Business Journal 40 Under 40 list as one of the top business leaders in the state. Brad has a degree in business with an Information Systems concentration from the Indiana University Kelley School of Business.

 Segment Overview: Brad Bostic, CEO of hc1.com, an award-winning healthcare CRM, discusses how artificial intelligence can mine clinical data lakes and be useful in dealing with opioid abuse and other public health issues.

Read More

Work of a Clinical Addictions Specialist Focusing on Relationship Addictions [transcript] [audio]

Guest: Roseann Rook, CADC  

Presenter: Neal Howard

Guest Bio: As a Clinical Addictions Specialist, Roseann is responsible for conducting psycho-educational and process groups as well as providing individual counseling for addiction treatment including co-occurring disorders such as Eating Disorders and Mood Disorders at Timberline Knolls. She specializes in Process Addictions with a strong focus on Relationship Addictions. Roseann was instrumental in the development of Timberline Knolls’ Addiction Program and the implementation of addressing Process Addictions into the curriculum. As a member of Timberline Knolls’ Clinical Development Institute, she has presented locally and at National conferences. Roseann has worked in the addictions field for 23 years starting at Aunt Martha’s Youth Service as an addiction counselor moved on to counsel MISA clients at Grand Prairie Services followed by working for the YMCA Network for Counseling and Youth Development as an Addictions Counselor and Crisis worker. She returned to Grand Prairie Services for a brief stint to develop and implement an out-patient program before joining Timberline Knolls in 2006.

Segment Overview: Roseann Rook, CADC, discusses her work as a Clinical Addictions Specialist at Timberline Knolls Residential Treatment Center, located just outside of Chicago. She specializes in Process Addictions with a strong focus on Relationship Addictions.

Read More

Sickle Cell Disease and the African-American Community [transcript] [audio]

Guest: Dr. Ted W. Love

Presenter: Neal Howard

Guest Bio: Dr. Love joined GBT in June 2014 as President and Chief Executive Officer with broad leadership and management experience in the biotech/pharmaceutical industry. Before that, he was Executive Vice President, Research and Development and Technical Operations at Onyx Pharmaceuticals, Inc., where he played an instrumental role in initiating and completing several of Onyx’s first Phase 3 clinical trials. Prior to Onyx, Dr. Love served as President, Chief Executive Officer and Chairman of Nuvelo, Inc., where he led growth of the company to a market capitalization of $1 billion. Prior to that, he served as Senior Vice President, Development at Theravance, Inc. Earlier in his career, Dr. Love held a number of senior management positions in medical affairs and product development at Genentech, where he served as Chairman of Genentech’s Product Development Committee. Dr. Love has served as a consultant in medicine in the Department of Cardiology at the Massachusetts General Hospital. He currently serves on the board of directors of Amicus Therapeutics, Inc., and Cascadian Therapeutics (formerly Oncothyreon). Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School. He completed a residency in internal medicine and a fellowship in cardiology at the Massachusetts General Hospital.

Segment Overview: Dr. Ted W. Love, CEO of Global Blood Therapeutics, Inc. (GBT) discusses sickle cell disease (SCD), the drug Voxelotor currently in development, and the social issues surrounding treating patients with SCD.

Read More

Teladoc and Telemedicine Helping the Mentally Ill [transcript] [audio]

Guest: Dr. Monika Roots

Presenter: Neal Howard

Guest Bio: Dr. Monika Roots is Vice President of health services and senior medical director of Behavioral Health for Teladoc. She is responsible for ensuring the high-quality clinical standards of Teladoc’s comprehensive tele-behavioral services. Her work has been featured at several national conferences, in addition to multiple journals including Clinical Psychiatry News, Boston Globe, Health 2.0, Techdot MN and Modern Physician. Dr. Roots is also an adjunct professor at the University of Wisconsin-Madison and a physician utilization reviewer for several large insurers. She is a graduate of Carleton College, received her M.D. from University of Sint Eustatius, and then completed her adult psychiatry residency at the University of Minnesota. She then went on to complete a fellowship in child/adolescent psychiatry, also at the University of Minnesota.

Segment Overview: Dr. Monika Roots, Vice President of health services and senior medical director of behavioral health for Teladoc, the world’s largest and most trusted telehealth provider,  discusses tackling mental health issues through telemedicine. People who do not have the time or resources to go out and get the help they need can now conveniently get help to understand their own mental health, have their treatment progress monitored and even be prescribed medication if needed.

Ketamine – Alternative Treatment for Some Mental Illness [transcript] [audio]

Guest: Dr. Steven Levine

Presenter: Neal Howard

Guest Bio: Dr. Steven Levine is a board-certified psychiatrist and psychotherapist, and the founder and CEO of Actify Neurotherapies (formerly Ketamine Treatment Centers), a network of 10 medical centers across the U.S. He pioneered the clinical use of intravenous ketamine as a fast-acting treatment for major depression and other mental illnesses, including anxiety, bipolar depression, obsessive compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). A Phi Beta Kappa graduate from The Johns Hopkins University, Dr. Levine received a medical degree from Tulane University Medical School. He also maintains a solo private practice in Princeton, NJ. He is heavily involved with the medical community at large, serving as a Diplomate of the American Board of Psychiatry and Neurology, and Vice President of the American Society of Ketamine Physicians, of which he is a founding member. He sits on the board of trustees of Trinity Counseling Service, a nonprofit organization that provides licensed professional counseling, wellness, and educational services to the local community in Princeton, NJ. He is also a member of the American Psychiatric Association and the New Jersey Psychiatric Association.

Dr. Levine has been quoted extensively as an expert on ketamine infusion treatment in media outlets, including Bloomberg BusinessWeek, Glamour, NBC Nightly News, NPR, Psychology Today, The New York Daily News, and The Washington Post. He resides in NJ with his wife and children. In his free time, he is an avid reader and slow, but spirited, CrossFit enthusiast.

Segment Overview: Dr. Steven Levine discusses the clinical use of intravenous ketamine as a fast-acting alternative treatment for depression and other mental illnesses, such as anxiety, OCD and PTSD. https://ktcpartnership.com/

A Near Death Experience Transforms a Physician and Her Practice [transcript] [audio]

 Segment Overview: Dr. Rana Awdish, MD, Director of the Pulmonary Hypertension Program and critical care medicine at Henry Ford hospital in Detroit discusses her own near death experience that transformed her medical care approach.

Guest: Dr. Rana Awdish, MD

Presenter: Neal Howard

Guest Bio: Dr. Rana Awdish is the Director of the Pulmonary Hypertension Program and critical care medicine. She believes in a patient-centered approach to health and wellness. Her research interests focus on exercise for Pulmonary Hypertension (PH), PH in liver disease and transplant, and improving communication in health care. Dr. Awdish has received the Tom Lantos Grant Pulmonary Hypertension Association Community Service Award, and the Speak Up Hero Award.

Applied DNA Sciences – Pharmaceutical Supply Chain Security [transcript] [audio]

 Segment Overview: Bob Miglani, Chief of Business Development at Applied DNA Sciences discusses securing the pharmaceutical supply chain which is a large and growing issue facing pharma companies today. Applied DNA Sciences uses DNA molecular taggant technology to help secure, trace and track the pharmaceutical supply chain.

Guest: Bob Miglani  

Presenter: Neal Howard

Guest Bio: Mr. Bob Miglani is Chief of Business Development at Applied DNA Sciences. Prior to that he was with Pfizer for 23 years, where he served in a series of roles with increasing responsibility, most recently as Senior Director, External Medial Affairs. He is a thought leader who frequently speaks at business, scientific and healthcare forums. Over the course of his career, Mr. Miglani has held diverse global positions encompassing sales, marketing research, strategy, pricing & reimbursement, public affairs and policy, market access, patient advocacy, communications and partnership development.

BetterAir – Probiotic Air & Surface Purifier [transcript] [audio]

Segment Overview: In this Health Supplier Segment, Taly Dery, CEO of BetterAir discusses how probiotics can be used to purify the air quality and surfaces inside hospitals and why probiotics are the most effective solution in breaking down biofilm-harboring, antibiotic-resistant organisms. She also discusses how conventional cleaning and purification methods inadequately disinfect medical equipment, which is the leading cause of Hospital-Acquired Infections.

Guest: Taly Dery

Presenter: Neal Howard

Guest Bio: Taly Dery is the CEO of Better Air North America, LLC, a market developer of the world’s first probiotic air and surface purifier. Mrs. Dery is also a partner in a high-growth CPA firm and CEO of Holy Herbs, an organic, natural skin care and supplement company.  She is active in many organizations, including “Larger than Life” a nonprofit association that supports children with cancer.

Healthcare Branding [transcript] [audio]

Segment Overview: In this Health Supplier segment, Vince Parry discusses the healthcare branding industry, what works, what doesn’t, and his book, “Identity Crisis:  Health Care Branding’s Hidden Problems And Proven Strategies To Solve Them” http://parrybrandinggroup.com/

Guest: Vince Parry

Presenter: Neal Howard

Guest Bio: Vince Parry, a 30-year veteran of the healthcare branding industry, is the founder of the New York-based Parry Branding Group and the author of Identity Crisis: Healthcare Branding’s Hidden Problems and Proven Strategies to Solve Them (2017).  Parry has helped lead the launch and guide the branding of many iconic healthcare identities, such as Lipitor and Botox, and has also been instrumental in the branding of Colgate Total, as well as the New York State of Opportunity campaign for New York. He was previously the Chief Branding Officer at inVentiv Health, the Founder and President of Y Brand, the Founder and President of GSW Worldwide NY and the Chief Creative Officer at Sudler & Hennessey. Among his clients have been Merck, Johnson & Johnson, Eli Lilly, Bayer Health Care, Lever and Maimonides Medical Center.

MiMedx and AmnioFix [transcript] [audio]

Segment Overview: Dr. Alfred Gellhorn discusses his experience with MiMedx Amniofix regenerative biologics and its potential to reduce reliance on opioids. Dr. Gellhorn is Assistant Professor of Clinical Rehabilitation Medicine, Director of Sports Medicine at Weill Cornell Medicine.

Guest: Dr. Alfred Gellhorn, MD

Presenter: Neal Howard

Guest Bio: Dr. Alfred Gellhorn is a Weill Cornell Associate Professor and physician in the Department of Rehabilitation Medicine, and also the Director of Sports Medicine for the Department of Rehabilitation Medicine. His clinical interests include regenerative treatments of musculoskeletal injuries. He treats a wide range of musculoskeletal and sports injuries, with a non-operative, patient-centered approach that focuses on maximizing function and optimizing quality of life. He uses state of the art tools such as high-resolution musculoskeletal ultrasound for both diagnosis and for precise guidance of treatments. Dr Gellhorn is board certified in Rehabilitation Medicine and Sports Medicine, and holds additional credentials in Musculoskeletal Sonography.